Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept for relapsing non-severe granulomatosis with polyangiitis
2013-005535-24Phase 3Unknown
- Sponsor
- University of South Florida
- Start
- Dec 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of abatacept in granulomatosis with polyangiitis (GPA), sponsored by University of South Florida. Primary endpoint: Treatment failure rate through 12 months. Status: unknown.
02
Drugs
abatacept
03
Conditions
granulomatosis with polyangiitis (GPA)
Beyond the preview
Go deeper on 2013-005535-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005535-24.